<DOC>
	<DOCNO>NCT00492908</DOCNO>
	<brief_summary>A Randomized Comparison Titanium-Nitride-Oxide Coated Stent ( Helistent Titan2 , Hexacath ) With Zotarolimus-Eluting Stent ( EndeavorTm , Medtronic ) Percutaneous Coronary Intervention</brief_summary>
	<brief_title>Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent</brief_title>
	<detailed_description>Objectives : The purpose study compare Titanium-Nitride-Oxide Coated Stent ( Helistent Titan2 , Hexacath ) Zotarolimus-Eluting Stent ( EndeavorTm , Medtronic ) non-inferiority trial . Design : Prospective , multi-center , randomize , non-inferiority trial conduct 3 Swiss interventional cardiology center . Patients randomize single-blind fashion ( 1:1 randomization ) either Titanium-Nitride-Oxide Coated Stent ( Helistent Titan2 , Hexacath ) Zotarolimus-Eluting Stent ( EndeavorTm , Medtronic ) . Study Population : Patients symptomatic coronary artery disease include patient chronic stable angina , silent ischemia , unstable angina , non-ST elevation myocardial infarction , qualify percutaneous coronary intervention Antiplatelet Therapy : Aspirin 100 mg qd indefinitely ; Clopidogrel 75 mg qd 3 month Enrollment : A total 300 patient enrol All patient undergo repeat angiography 6-8 month . All patient follow 5 year .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>The following patient eligible inclusion 1 . Age â‰¥18 year 2 . Symptomatic coronary artery disease include patient chronic stable angina , silent ischemia , unstable angina , nonST elevation myocardial infarction 3 . Presence one coronary artery stenoses &gt; 50 % native coronary artery 2.25 4.0 mm diameter cover one multiple stent ; 4 . No limitation number treat lesion , vessel , lesion length 1 . Pregnancy 2 . Known intolerance aspirin , clopidogrel , heparin , stainless steel , titan , zotarolimus contrast material 3 . Inability provide inform consent 4 . Currently participate another trial reach first endpoint 5 . ST segment elevation myocardial infarction ( STEMI )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Coronary Revascularization</keyword>
	<keyword>Titanium-Nitride-Oxide Coated Stent</keyword>
	<keyword>Zotarolimus-Eluting Stent</keyword>
</DOC>